Loading data
BGMNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 37.92 m USD | 25.1 m USD | 46.47 m USD | 64.86 m USD |
| Cost of revenue | 31.61 m USD | 20.98 m USD | 44.72 m USD | 58.63 m USD |
| Gross profit | 6.31 m USD | 4.11 m USD | 1.75 m USD | 6.23 m USD |
| Research and development expense | 672.67 k USD | 1.36 m USD | 568.47 k USD | 1.22 m USD |
| Selling, general and administrative expense | 18.22 m USD | 3.32 m USD | 3.79 m USD | 4.13 m USD |
| Operating profit | -12.58 m USD | -563.77 k USD | -2.61 m USD | 2.1 m USD |
| Profit before tax | -19.94 m USD | -2.14 m USD | -7.9 m USD | 1.56 m USD |
| Income tax expense | 277.79 k USD | -619.98 k USD | 219.17 k USD | 194.3 k USD |
| Net income (reported basis) | -19.94 m USD | -1.44 m USD | -7.78 m USD | 1.08 m USD |
| Net income attributable to common shareholders | -19.94 m USD | -1.44 m USD | -7.78 m USD | 1.08 m USD |
| Basic earnings per share | -0.18 USD/share | -0.2 USD/share | -1.08 USD/share | 0.15 USD/share |
| Diluted earnings per share | -0.18 USD/share | -0.2 USD/share | -1.08 USD/share | 0.15 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.